Regulated Information - Global

Filter

Period

Filter by

Reset

Showing: 1 – 05 of 127 Regulated Information

Show

Sort

Ipsen delivers a strong sales performance in the first quarter of 2022

– 27 April 2022

27 April 2022

Ipsen delivers a strong sales performance in the first quarter of 2022

Q1 2022 – Sales presentation (1,014.94 KB)

Webcast Q1 2022

Ipsen presents strong full-year 2021 results and enters into exclusive negotiations to divest its Consumer Healthcare business

– 11 February 2022

11 February 2022

Ipsen presents strong full-year 2021 results and enters into exclusive negotiations to divest its Consumer Healthcare business

Attachment

FY 2021 – Results presentation (2.17 MB)

Webcast replay FY 2021

Ipsen and GENFIT enter into exclusive licensing agreement for elafibranor, a Phase III asset evaluated in Primary Biliary Cholangitis, as part of a long-term global partnership

– 17 December 2021

17 December 2021

Ipsen and GENFIT enter into exclusive licensing agreement for elafibranor, a Phase III asset evaluated in Primary Biliary Cholangitis, as part of a long-term global partnership

Ipsen delivers strong sales growth for the first nine months and improves its full-year guidance

– 21 October 2021

21 October 2021

Ipsen delivers strong sales growth for the first nine months and improves its full-year guidance

YTD 2021 – Sales presentation (851.58 KB)

Share buyback program – Ipsen reporting from 19 to 23 July 2021 – Detailed

– 11 October 2021

11 October 2021

Share buyback program – Ipsen reporting from 19 to 23 July 2021 – Detailed

This article or press release has no online content. Please download the associated documents for more information.

1 … 20 21 22 23 24 25 26

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.